This document summarizes the history of consumer participation in the Victorian alcohol and other drug sector. It discusses the challenges faced in establishing consumer participation, such as lack of policy, funding, and knowledge. It outlines how organizations like the Association of Participating Service Users (APSU) and UnitingCare ReGen have worked to address these challenges through developing policies, training programs, advisory boards, and ensuring consumer participation is included in funding agreements. While progress has been made, ongoing cultural change is still needed to fully achieve effective consumer participation.
Implementation of Responsible Supply Chain Management within the Healthcare S...Sherif Zaki Tehemar
This document outlines steps for implementing a corporate social responsibility program within a company's supply chain. It discusses establishing a supplier code of conduct, prioritizing suppliers based on their relationship and empowerment level, communicating expectations, conducting self-assessments, monitoring performance through audits and measures, and taking corrective actions with suppliers that do not meet standards. The goal is to encourage suppliers to voluntarily adopt more ethical practices over time through cooperation rather than immediate termination.
This document discusses development assistance for global health issues like AIDS. It shows that while funding for AIDS assistance increased from 2002 to 2008, it has declined since. It also discusses the debate around coordinating different donor agencies that provide health aid for specific diseases separately. While increased coordination seems obvious, different agencies have separate targets and structures that have made overall coordination challenging to achieve. The document argues that a common fund and allowing donors to support ministry campaigns while keeping priorities could help address this issue and get past obvious solutions to actually achieve more coordination.
This document summarizes research on the costs, cost-effectiveness, and potential health impacts of scaling up an Integrated Prevention Campaign (IPC) globally. The research finds that IPC is very cost-effective in the top 10 countries with the highest disease burden, and even more so in subsequent campaigns as costs decline. Implementing IPC in the top 40 countries could avert 46 million Disability-Adjusted Life Years (DALYs) and save $1.4 billion. The conclusion is that scaling up IPC globally has strong potential for efficiently improving public health outcomes.
This document discusses using private sector approaches and information communication technologies (ICT) to scale up family planning programs in India. It proposes partnering with private medical providers and manufacturers to distribute contraceptives. It also describes developing a mobile phone-based fertility awareness app called CycleTel and conducting pilot tests of it in India. Preliminary results found interest among users and a willingness to pay for the service. Next steps include further pilot testing, software development, and scaling up programs within India and other countries.
This document discusses considerations for launching a specialty product. It emphasizes the importance of demonstrating value through clinical and cost effectiveness data, ensuring patient access to therapy, and generating data to support value claims. It provides tips for defining goals, building an integrated team, and refining a launch strategy focused on these priorities. The strategy should consider innovative contracting, outcomes-based agreements, and communicating the right evidence to the right audiences. Overall, the document stresses that demonstrating value is critical for specialty product launches, especially with increased attention on healthcare costs.
mHealth Israel_UK Healthcare, Retail and DTC Market OverviewLevi Shapiro
Overview of UK Healthcare, retail and direct to consumer market by Jeremy Cummin and Steve Hazelwood. Includes description of the NHS buying process, alternative market entry strategies and key considerations for success in the UK retail and consumer sectors.
This document summarizes the history of consumer participation in the Victorian alcohol and other drug sector. It discusses the challenges faced in establishing consumer participation, such as lack of policy, funding, and knowledge. It outlines how organizations like the Association of Participating Service Users (APSU) and UnitingCare ReGen have worked to address these challenges through developing policies, training programs, advisory boards, and ensuring consumer participation is included in funding agreements. While progress has been made, ongoing cultural change is still needed to fully achieve effective consumer participation.
Implementation of Responsible Supply Chain Management within the Healthcare S...Sherif Zaki Tehemar
This document outlines steps for implementing a corporate social responsibility program within a company's supply chain. It discusses establishing a supplier code of conduct, prioritizing suppliers based on their relationship and empowerment level, communicating expectations, conducting self-assessments, monitoring performance through audits and measures, and taking corrective actions with suppliers that do not meet standards. The goal is to encourage suppliers to voluntarily adopt more ethical practices over time through cooperation rather than immediate termination.
This document discusses development assistance for global health issues like AIDS. It shows that while funding for AIDS assistance increased from 2002 to 2008, it has declined since. It also discusses the debate around coordinating different donor agencies that provide health aid for specific diseases separately. While increased coordination seems obvious, different agencies have separate targets and structures that have made overall coordination challenging to achieve. The document argues that a common fund and allowing donors to support ministry campaigns while keeping priorities could help address this issue and get past obvious solutions to actually achieve more coordination.
This document summarizes research on the costs, cost-effectiveness, and potential health impacts of scaling up an Integrated Prevention Campaign (IPC) globally. The research finds that IPC is very cost-effective in the top 10 countries with the highest disease burden, and even more so in subsequent campaigns as costs decline. Implementing IPC in the top 40 countries could avert 46 million Disability-Adjusted Life Years (DALYs) and save $1.4 billion. The conclusion is that scaling up IPC globally has strong potential for efficiently improving public health outcomes.
This document discusses using private sector approaches and information communication technologies (ICT) to scale up family planning programs in India. It proposes partnering with private medical providers and manufacturers to distribute contraceptives. It also describes developing a mobile phone-based fertility awareness app called CycleTel and conducting pilot tests of it in India. Preliminary results found interest among users and a willingness to pay for the service. Next steps include further pilot testing, software development, and scaling up programs within India and other countries.
This document discusses considerations for launching a specialty product. It emphasizes the importance of demonstrating value through clinical and cost effectiveness data, ensuring patient access to therapy, and generating data to support value claims. It provides tips for defining goals, building an integrated team, and refining a launch strategy focused on these priorities. The strategy should consider innovative contracting, outcomes-based agreements, and communicating the right evidence to the right audiences. Overall, the document stresses that demonstrating value is critical for specialty product launches, especially with increased attention on healthcare costs.
mHealth Israel_UK Healthcare, Retail and DTC Market OverviewLevi Shapiro
Overview of UK Healthcare, retail and direct to consumer market by Jeremy Cummin and Steve Hazelwood. Includes description of the NHS buying process, alternative market entry strategies and key considerations for success in the UK retail and consumer sectors.
The document provides an overview of materials and methods used for a project report on public relations and corporate communication as marketing tools for Fortis Hospital Shalimar Bagh. It includes an introduction to Fortis Healthcare, the healthcare industry, objectives of healthcare marketing, and the need for public relations. Key points covered are patient education, government compliance, and interacting with physicians, nurses and other stakeholders.
HealthVine is a proposed mobile healthcare information management service that allows users to store and manage all their health information such as medical records, prescriptions, and bills in one place. This provides easy access to medical history during emergencies. HealthVine aims to fill the gap in credible healthcare information resources in India by connecting patients, doctors, and pharmacists. It plans to launch initially in India through partnerships with insurance companies, pharmacists, corporations, and educational groups to provide users convenient access to their timely and updated health information. HealthVine's vision is to become a world-class provider of seamless and timely healthcare information management.
Enabling Registration and Personalised Marketing for Health Care Professional...Gerry Alden
Janrain provides identity management and authentication solutions that have helped leading pharmaceutical companies connect with healthcare providers, validate their credentials, and support marketing programs. Janrain's solutions include a unified data repository for global identity management, validation of professional identities, management of private customer profiles, and support for targeted marketing campaigns while complying with privacy mandates.
The document summarizes the services provided by The Navicor Group, a full-service healthcare marketing agency that specializes in oncology. The agency understands the oncology market, has extensive launch experience, and works with both large and small biotech and pharmaceutical clients. The agency provides a wide range of services including outsourced sales teams, advertising, digital marketing, medical education, clinical research, and consulting. Case studies demonstrate the agency's strategic approach to overcoming marketing challenges and changing perceptions within the oncology community.
The document discusses how pharmaceutical companies can leverage social media to enhance pharmacovigilance and patient safety. It proposes a 4-step social media model: 1) establish keywords related to side effects, 2) listen to patient conversations on social media, 3) generate reporting and analytics on collected data, 4) respond to patient concerns. Adopting this approach allows companies to identify risks early, minimize reputation risks, and manage adverse events, helping boost patient safety.
The document discusses how pharmaceutical companies can leverage social media to enhance pharmacovigilance and patient safety. It proposes a 4-step social media model: 1) establish keywords related to side effects, 2) listen to patient conversations on social media, 3) generate reporting and analytics on collected data, 4) respond to patient concerns. Adopting this approach allows companies to identify risks early, minimize reputation risks, and manage adverse events, helping boost patient safety.
This document discusses an integrated value chain in the pharmaceutical industry. It covers various stages of the value chain enabled by e-technologies, including research and development, production, marketing, sales, and customer relationship management. Key points covered include e-recruitment, e-trials, e-submission, e-manufacturing, digital e-marketing strategies, and the role of technology in connecting patients and healthcare organizations.
This document provides an overview of planning and marketing strategies for a proposed 300-bed corporate hospital. It discusses identifying patient needs, developing new services, satisfying patients, and marketing at different stages of hospital growth. Key aspects of hospital marketing include promoting quality treatment, medical tourism, major surgeries, and using social media. The roles of marketers in healthcare are also examined. Effective marketing techniques for hospitals include demonstrations, public relations, advertisements, media interviews, and using various modes of publicity.
14th Cairo Marketing Club (Digital World for Pharma) by Dr. Fayza Elshatby & ...Mahmoud Bahgat
14th Cairo Marketing Club (Digital World for Pharma) by Dr. Fayza Elshatby & Dr.Mahmoud Hamdy
*#Mahmoud_Bahgat*
*#Marketing_Club*
للاشتراك في نادي التسويق بالشرق الاوسط
*If you are a Marketer now*
To Join our whatsapp &Monthly Meeting in Middle East Cities
Send me ur data on Whatsap
00966569654916
*Fill ur data here as speaker or member*
https://lnkd.in/efkTE7T
Join now
*Marketing Club Facebook Page*
https://lnkd.in/gm4c4hD
*Marketing Club Facebook Group*
https://lnkd.in/gX-5au5
*Egyptian Pharmacists Society Facebook Page*
https://lnkd.in/fucnv_5
•••••••••••••••••••••••••••••
*#Mahmoud_Bahgat*
00966568654916
لخدمات التسويق والدعاية والاعلان
*#Legendary_ADLAND*
Complete Marketing Solutions
*www.LegendaryADLAND.com*
•••••••••••••••••••••••••••••
للحصول على اقامة او شركة في اوروبا
*#Legendary_Europe*
Europe Companies & Residency
*www.LegendaryEurope.info*
•••••••••••••••••••••••••••••
*Contact Bahgat*
M.Bahgat@TheLegendary.Info
Benefits of Neuro-Psychiatry Pharma PCDSanityPharma
We offer you an open chance as a PCD pharma franchise for neuro ranges. Here we have some benefits considering these factors you can find the best Neuro-Psychiatry Pharma PCD company.
Healthcare Reform & Physician Loyalty: What Can CRM Do To Support ACOs?Perficient, Inc.
Martin Sizemore, Enterprise Architect at Perficient, and Lisa Anderson, CRM Solution Architect at Perficient, discuss Consumerism in Healthcare, Physician Practice Challenges & Alignment, and provide a Physician Loyalty Campaign Demo
With a focus on providing high-quality, lower-cost care, the healthcare industry has been looking to the retail industry for strategies used to engage and empower consumers. Lessons learned include how to use the retail setting as a medium for providing care and how to engage consumers outside of the care setting by using technology.
What is often neglected when assessing retail industry tactics is their core competency of using data insights to motivate and incentivize changes in consumer behavior. Connected Health solutions provide streams of valuable information that can be mined and analyzed to achieve business objectives.
Perficient's healthcare and retail experts demonstrated how data can be leveraged to:
-Transform passive recipients of care into active participants in care
-Mass customize messaging aligned with population health initiatives
-Achieve outreach objectives that convert unknown consumers into patients/members
-Improve care and lower healthcare costs
Pharmaceutical companies need to leverage technology more strategically in their marketing and communications. Technology is changing how providers and patients interact and receive information. It allows access to more data and provides opportunities to improve patient engagement, adherence, and ROI measurement. Pharma companies must capitalize on technology now to engage customers and measure impact, before competitors do. Technology presents opportunities but also challenges pharmaceutical marketers to change their sales and marketing approaches.
Overview of aspects of pharma's value added services and its primary aspects to deliver them.
Learn what others do and reflect how it's an opportunity for your pharma company..
Pov healthcare communication draft_20111204thomeu2012
The document discusses communication challenges in the pharmaceutical industry. It notes that while doctors want higher quality information from fewer sales reps, pharma companies face difficulties meeting these demands. Regulations heavily constrain advertising content to doctors. As a result, communication often lacks impact, creativity, and relevance for doctors. The industry needs to fine-tune rules to allow more relevant messaging while maintaining information clarity and attention to receptors' needs. Improved knowledge of customers and more tailored content, channels, and timing could help pharma companies better communicate about health care.
BMC Holistic Health & Retail ClinicsLauren Peters
The document appears to be a pre-assignment for a service design course. It provides three potential topics or trends for the assignment:
1. The rise of religious "nones" and how this trend could impact traditional and organized religion.
2. The increasing reliance on technology and how "our heads are in the cloud." This could relate to issues around dependency on computers and technology failures.
3. The idea that "nature is over" and how humans now dominate nature, questioning the balance between nature and human-made environments.
The document asks the student to choose one of the three topics or trends for their assignment and provides example prompts for each relating to different industries and business models.
A holistic and systematic approach to market development can overcome barriers to serving insurance to the low-income population. Collaboration between supervisors/regulators, industry players, policy makers, and donors is already showing positive results in some countries.
Baystate Health marketing at Harvard UniversityRenown Health
The document describes how Baystate Health redesigned its cancer care program through a partnership between marketing and physicians to improve the patient experience, which led to increased patient satisfaction, physician referrals, and program volumes. Key steps included engaging patients and staff in the design process, aligning marketing and operations around a brand focused on expertise and relationships, and transforming the culture to deliver on promises to patients.
Presentation by:
Joseph Guydish
Catherine Saucedo
University of California, San Francisco
County Behavioral Health Directors Association of California
September 25, 2019
Disparities in health outcomes are a result of a myriad of socio-ecological factors that are linked to education, employment, income, discrimination based on race/ethnicity, gender, religion, sexual orientation, geographic location, mental health and/or disability. These factors are commonly referred to as social determinants of health (SDOH). The World Health Organization defines SDOH as the conditions in which people are born, grow up, work and live and the structures and systems that shape the daily conditions of life. There has been a great deal of research focused on SDOH in the past decade that is critical to informing policy and practice necessary to promote health equity. However, it is also important to acknowledge that this concept is not new. Unacceptable health disparities remain despite substantial evidence, over the past century, which shows SDOH are at the root cause of health disparities.
More Related Content
Similar to The Role of the Private Sector in Integrated Prevention Campaigns
The document provides an overview of materials and methods used for a project report on public relations and corporate communication as marketing tools for Fortis Hospital Shalimar Bagh. It includes an introduction to Fortis Healthcare, the healthcare industry, objectives of healthcare marketing, and the need for public relations. Key points covered are patient education, government compliance, and interacting with physicians, nurses and other stakeholders.
HealthVine is a proposed mobile healthcare information management service that allows users to store and manage all their health information such as medical records, prescriptions, and bills in one place. This provides easy access to medical history during emergencies. HealthVine aims to fill the gap in credible healthcare information resources in India by connecting patients, doctors, and pharmacists. It plans to launch initially in India through partnerships with insurance companies, pharmacists, corporations, and educational groups to provide users convenient access to their timely and updated health information. HealthVine's vision is to become a world-class provider of seamless and timely healthcare information management.
Enabling Registration and Personalised Marketing for Health Care Professional...Gerry Alden
Janrain provides identity management and authentication solutions that have helped leading pharmaceutical companies connect with healthcare providers, validate their credentials, and support marketing programs. Janrain's solutions include a unified data repository for global identity management, validation of professional identities, management of private customer profiles, and support for targeted marketing campaigns while complying with privacy mandates.
The document summarizes the services provided by The Navicor Group, a full-service healthcare marketing agency that specializes in oncology. The agency understands the oncology market, has extensive launch experience, and works with both large and small biotech and pharmaceutical clients. The agency provides a wide range of services including outsourced sales teams, advertising, digital marketing, medical education, clinical research, and consulting. Case studies demonstrate the agency's strategic approach to overcoming marketing challenges and changing perceptions within the oncology community.
The document discusses how pharmaceutical companies can leverage social media to enhance pharmacovigilance and patient safety. It proposes a 4-step social media model: 1) establish keywords related to side effects, 2) listen to patient conversations on social media, 3) generate reporting and analytics on collected data, 4) respond to patient concerns. Adopting this approach allows companies to identify risks early, minimize reputation risks, and manage adverse events, helping boost patient safety.
The document discusses how pharmaceutical companies can leverage social media to enhance pharmacovigilance and patient safety. It proposes a 4-step social media model: 1) establish keywords related to side effects, 2) listen to patient conversations on social media, 3) generate reporting and analytics on collected data, 4) respond to patient concerns. Adopting this approach allows companies to identify risks early, minimize reputation risks, and manage adverse events, helping boost patient safety.
This document discusses an integrated value chain in the pharmaceutical industry. It covers various stages of the value chain enabled by e-technologies, including research and development, production, marketing, sales, and customer relationship management. Key points covered include e-recruitment, e-trials, e-submission, e-manufacturing, digital e-marketing strategies, and the role of technology in connecting patients and healthcare organizations.
This document provides an overview of planning and marketing strategies for a proposed 300-bed corporate hospital. It discusses identifying patient needs, developing new services, satisfying patients, and marketing at different stages of hospital growth. Key aspects of hospital marketing include promoting quality treatment, medical tourism, major surgeries, and using social media. The roles of marketers in healthcare are also examined. Effective marketing techniques for hospitals include demonstrations, public relations, advertisements, media interviews, and using various modes of publicity.
14th Cairo Marketing Club (Digital World for Pharma) by Dr. Fayza Elshatby & ...Mahmoud Bahgat
14th Cairo Marketing Club (Digital World for Pharma) by Dr. Fayza Elshatby & Dr.Mahmoud Hamdy
*#Mahmoud_Bahgat*
*#Marketing_Club*
للاشتراك في نادي التسويق بالشرق الاوسط
*If you are a Marketer now*
To Join our whatsapp &Monthly Meeting in Middle East Cities
Send me ur data on Whatsap
00966569654916
*Fill ur data here as speaker or member*
https://lnkd.in/efkTE7T
Join now
*Marketing Club Facebook Page*
https://lnkd.in/gm4c4hD
*Marketing Club Facebook Group*
https://lnkd.in/gX-5au5
*Egyptian Pharmacists Society Facebook Page*
https://lnkd.in/fucnv_5
•••••••••••••••••••••••••••••
*#Mahmoud_Bahgat*
00966568654916
لخدمات التسويق والدعاية والاعلان
*#Legendary_ADLAND*
Complete Marketing Solutions
*www.LegendaryADLAND.com*
•••••••••••••••••••••••••••••
للحصول على اقامة او شركة في اوروبا
*#Legendary_Europe*
Europe Companies & Residency
*www.LegendaryEurope.info*
•••••••••••••••••••••••••••••
*Contact Bahgat*
M.Bahgat@TheLegendary.Info
Benefits of Neuro-Psychiatry Pharma PCDSanityPharma
We offer you an open chance as a PCD pharma franchise for neuro ranges. Here we have some benefits considering these factors you can find the best Neuro-Psychiatry Pharma PCD company.
Healthcare Reform & Physician Loyalty: What Can CRM Do To Support ACOs?Perficient, Inc.
Martin Sizemore, Enterprise Architect at Perficient, and Lisa Anderson, CRM Solution Architect at Perficient, discuss Consumerism in Healthcare, Physician Practice Challenges & Alignment, and provide a Physician Loyalty Campaign Demo
With a focus on providing high-quality, lower-cost care, the healthcare industry has been looking to the retail industry for strategies used to engage and empower consumers. Lessons learned include how to use the retail setting as a medium for providing care and how to engage consumers outside of the care setting by using technology.
What is often neglected when assessing retail industry tactics is their core competency of using data insights to motivate and incentivize changes in consumer behavior. Connected Health solutions provide streams of valuable information that can be mined and analyzed to achieve business objectives.
Perficient's healthcare and retail experts demonstrated how data can be leveraged to:
-Transform passive recipients of care into active participants in care
-Mass customize messaging aligned with population health initiatives
-Achieve outreach objectives that convert unknown consumers into patients/members
-Improve care and lower healthcare costs
Pharmaceutical companies need to leverage technology more strategically in their marketing and communications. Technology is changing how providers and patients interact and receive information. It allows access to more data and provides opportunities to improve patient engagement, adherence, and ROI measurement. Pharma companies must capitalize on technology now to engage customers and measure impact, before competitors do. Technology presents opportunities but also challenges pharmaceutical marketers to change their sales and marketing approaches.
Overview of aspects of pharma's value added services and its primary aspects to deliver them.
Learn what others do and reflect how it's an opportunity for your pharma company..
Pov healthcare communication draft_20111204thomeu2012
The document discusses communication challenges in the pharmaceutical industry. It notes that while doctors want higher quality information from fewer sales reps, pharma companies face difficulties meeting these demands. Regulations heavily constrain advertising content to doctors. As a result, communication often lacks impact, creativity, and relevance for doctors. The industry needs to fine-tune rules to allow more relevant messaging while maintaining information clarity and attention to receptors' needs. Improved knowledge of customers and more tailored content, channels, and timing could help pharma companies better communicate about health care.
BMC Holistic Health & Retail ClinicsLauren Peters
The document appears to be a pre-assignment for a service design course. It provides three potential topics or trends for the assignment:
1. The rise of religious "nones" and how this trend could impact traditional and organized religion.
2. The increasing reliance on technology and how "our heads are in the cloud." This could relate to issues around dependency on computers and technology failures.
3. The idea that "nature is over" and how humans now dominate nature, questioning the balance between nature and human-made environments.
The document asks the student to choose one of the three topics or trends for their assignment and provides example prompts for each relating to different industries and business models.
A holistic and systematic approach to market development can overcome barriers to serving insurance to the low-income population. Collaboration between supervisors/regulators, industry players, policy makers, and donors is already showing positive results in some countries.
Baystate Health marketing at Harvard UniversityRenown Health
The document describes how Baystate Health redesigned its cancer care program through a partnership between marketing and physicians to improve the patient experience, which led to increased patient satisfaction, physician referrals, and program volumes. Key steps included engaging patients and staff in the design process, aligning marketing and operations around a brand focused on expertise and relationships, and transforming the culture to deliver on promises to patients.
Similar to The Role of the Private Sector in Integrated Prevention Campaigns (20)
Presentation by:
Joseph Guydish
Catherine Saucedo
University of California, San Francisco
County Behavioral Health Directors Association of California
September 25, 2019
Disparities in health outcomes are a result of a myriad of socio-ecological factors that are linked to education, employment, income, discrimination based on race/ethnicity, gender, religion, sexual orientation, geographic location, mental health and/or disability. These factors are commonly referred to as social determinants of health (SDOH). The World Health Organization defines SDOH as the conditions in which people are born, grow up, work and live and the structures and systems that shape the daily conditions of life. There has been a great deal of research focused on SDOH in the past decade that is critical to informing policy and practice necessary to promote health equity. However, it is also important to acknowledge that this concept is not new. Unacceptable health disparities remain despite substantial evidence, over the past century, which shows SDOH are at the root cause of health disparities.
This evaluation report summarizes the findings of a partnership between the Too Small to Fail initiative and UCSF Benioff Children's Hospital Oakland to promote early literacy and brain development. The key findings were:
1) Parents recognized the importance of talking, reading and singing but engaged in these activities less frequently than recommended, especially reading.
2) A hospital clinic visit that provided messaging from doctors and literacy materials increased parents' awareness and planned behavior changes, especially among Spanish-speaking families.
3) Follow-up interviews found parents had retained messages, were using provided materials regularly, and expected to talk, read and sing more in the future with their children.
By Alicia LaFrance, MPH, MSW Janet Coffman, MPP, PhD, UCSF Health Workforce Research Center
Mobile integrated healthcare – community paramedicine (MIH-CP) is a new model of care that trains paramedics to deliver a broader range of services than traditional emergency response and transport of people to emergency departments (ED).
The purpose of this Health Policy Study is to better understand adolescents’ views on what are considered core components of the medical home and identify barriers to promoting adolescent health in relation to the medical home.
In addition, this study sought to better understand the needs and challenges in providing adolescents with access to medical homes—from the perspective of both adolescents and experts in adolescent health and medical home policy. To accomplish these goals, researchers conducted focus groups with adolescents, presented these findings to experts, and gathered experts’ reactions to the adolescents’ perspectives. This report includes a detailed description of the methods used for this study, followed by a summary of key focus group findings and the expert reactions to these findings.
PRL-IHPS Evaluation Presentation by Janet M. Coffman, MPP, PhD, Center for the Health Professions and The Philip R. Lee Institute for Health Policy Studies, UCSF
This document summarizes the findings of a webinar on emerging trends in California's RN labor market. It discusses surveys of Chief Nursing Officers and hospital HR directors that show perceptions of the RN labor market are trending toward shortage again, with higher vacancy rates, turnover, and difficulty recruiting experienced RNs. While most hospitals still hire new graduates, the percentage is decreasing, and some hospitals plan to decrease new graduate hiring in the future due to the high costs of transitioning them. Ensuring an adequate future nurse supply will require identifying ways to support nursing education and recruitment of experienced RNs.
A summary of an exploratory study of insurers of insurers and health plans designed to assess their readiness to implement the requirements of SB 138, California’s confidential health information privacy law. Authors: Jan Malvin, PhD, Sara Daniel, MPH, Claire D. Brindis, DrPH from the Philip R. Lee Institute for Health Policy Studies at UC San Francisco.
Current job trends in the RN labor market, where the jobs are, and estimates of future demand.
Presenters: Joanne Spetz, Professor at the
Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco;
Teri Hollingsworth, Vice President, Human Resources Services,
Hospital Association of Southern California;
Judee Berg, Executive Director of the California Institute for Nursing & Health Care
This document discusses sensitive health care services available without cost-sharing under the Affordable Care Act, including STI screening and treatment, contraception, and counseling services. It notes the importance of confidentiality for adolescents and young adults seeking these services. While federal and state laws provide some privacy protections, electronic health records pose new challenges to maintaining confidentiality. Features of EHRs like patient portals could allow parents access to an adolescent's confidential health information if not configured properly.
This report summarizes the findings from a survey of general acute care (GAC) hospital employers of registered nurses (RNs) in California, conducted in fall 2013. This is the fourth annual survey of hospital RN employers; together these surveys provide an opportunity to
evaluate overall demand for RNs in the state, and changes that have occurred as the economy in California has recovered from the economic recession that started in late 2007.
This document summarizes a policy brief on Explanation of Benefits (EOBs) and patient confidentiality. It discusses the tension between maintaining patient confidentiality, especially for adolescents and young adults seeking sensitive health services, and insurers' practice of sending EOBs to notify policyholders of medical claims and costs. While EOBs aim to prevent fraud, they can compromise confidentiality by revealing details of services received. The brief reviews legal contexts, case studies, and strategies to balance these competing priorities in light of expanding health insurance coverage under the Affordable Care Act. It describes a methodology involving interviews with 37 health care experts to inform potential policy solutions.
This document provides an executive summary of a report examining efforts to increase racial and ethnic diversity in U.S. medical schools from the 1960s to the 2000s. Some key findings include: 1) While diversity has increased overall, certain groups remain underrepresented; 2) A lack of physician workforce diversity can negatively impact access, quality and outcomes of care; 3) Federal and state laws have both advanced and impeded diversity efforts; 4) Legal frameworks for considering race in admissions vary by state; 5) Case studies of UCSF and Stanford medical schools found early and continued leadership in enrolling underrepresented groups. The full report analyzes policies, trends and case studies to understand interventions needed to further increase diversity.
The Affordable Care Act: Success or Failure?
Janet Coffman, MPP, PhD
Edward Yelin, PhD
GME Grand Rounds 4/15/14
UCSF San Francisco
http://medschool2.ucsf.edu/gme/
Presentation by Annette Gardner PhD, MPH
Assistant Professor, Department of Social and Behavioral Sciences,
and the Philip R. Lee Institute for Health Policy Studies, UCSF
Treating The Whole Person: Strategies for Integrating Care. Workshop for Physicians,
Mental Health Providers, ER nurses, Psychiatric Nurses, and Students
This document describes a new model for policy change through academic, civic, and community partnerships in San Francisco. The model brings together community groups, civic organizations, and academic experts from UCSF to improve health and reduce health disparities. Key partners include community coalitions, organizations, residents, UCSF institutes and programs, and city departments. The goal is to use academic research and expertise to help community and civic partners design scalable interventions that make a measurable impact on community health. Initial focus areas chosen are alcohol policy, children's oral health, hepatitis B quality improvement, and physical activity and nutrition.
Helene Levens Lipton, PhD, Department of Clinical Pharmacy, UCSF School of Pharmacy, Philip R. Lee Institute of Health Policy Studies;
Marilyn R. Stebbins, Department of Clinical Pharmacy, UCSF School of Pharmacy
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
ABDOMINAL TRAUMA in pediatrics part one.drhasanrajab
Abdominal trauma in pediatrics refers to injuries or damage to the abdominal organs in children. It can occur due to various causes such as falls, motor vehicle accidents, sports-related injuries, and physical abuse. Children are more vulnerable to abdominal trauma due to their unique anatomical and physiological characteristics. Signs and symptoms include abdominal pain, tenderness, distension, vomiting, and signs of shock. Diagnosis involves physical examination, imaging studies, and laboratory tests. Management depends on the severity and may involve conservative treatment or surgical intervention. Prevention is crucial in reducing the incidence of abdominal trauma in children.
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
The Role of the Private Sector in Integrated Prevention Campaigns
1. The Role of the Private Sector in
Integrated Prevention Campaigns
Anna York De La Cruz
UCSF Global Health Group
2. Presentation Objectives
Why focus on the private sector in Integrated
Prevention Campaigns?
Private sector actors and potential roles
The Social Franchising model
Key Lessons
3. The Majority of People in Developing
Countries are Treated in the Private Sector
58% 65% 78%
Kenya Nigeria India
Source: DHS & www.ps4h.org/globalhealthdata
4. Potential Private Sector Roles
Inputs and Commodities
Private companies can produce high quality and inexpensive
commodities
NGO partnerships like Nets for Life
Support, Data collection and information dissemination
Pharmacy, drug outlets/chains, drug detailers
Technology companies
Implementation
Corporate-run networks and campaigns
For-profit clinic, hospital, pharmacy chains
NGO-run social franchises
5. One Model: Social Franchising
Branding Franchisee
Training Clinic
Standards
Commoditie
Franchisee
Franchisor s
Clinic
Membership
fee
Requirements/ Franchisee
Standards Clinic
Goals
Quality * Equity * Cost-effectiveness * Health Impact
8. Lessons
Many innovative ways to engage the private sector in
IPCs
Provider networks of retailers, clinics, hospitals, NGOs, can
be leveraged for large-scale delivery operations in IPCs
Private companies can contribute to inputs and
communications
Funding for prevention is the biggest challenge, but
one that can be overcome
Need to work with the private sector to reach
everyone
Editor's Notes
Some brief context: The majority of people seek health care in the private sector in developing countries (DHS data). Pharmacies, retail outlets, for-profit clinics and hospitals, NGOS (though smallest percentage). We generally think of the wealthy as using the private sector, but its across income levels. While this is referring to service delivery, and includes informal providers, its still important to recognize what a big role the private sector already plays in healthcare and think about how these existing private sector actors can be utilized in Integrated prevention campaigns. The question is what are the specific opportunities for the private sector in IPCs?
Investments in large-scale production, novartis with malaria treatment, pharma companies have brought down ART costs similarly, VF with bednetsGSK has used pharma detailers to provide IEC materials while selling drugsTechnology: Cell phone reminders and other outreach/educational toolsIndependent drug shops are often the “first point of care” and very rooted and trusted in communities. We’re starting to look to these outlets for distribution of diagnostic and preventative tools, such as RDTs for malaria (Uganda, Nigeria, Myanmar), so again there is potential here to serve as an operational base / distribution point for IPCs. Living goods – door to door social commodity sales.
Variety of contractual and financing models adapted to different contexts, different levels of sustainability
This is a quickly growing model52 programs around the world reported in 2011The number has doubled since 2006Number of countries more than doubled since 2003
While this graph refers mostly to clinical services, we’re also seeing more and more programs that are introducing preventative services: child nutrition, cervical cancer screening, diagnostic testing for HIV and malaria, and a large part of their business relies on selling subsidized preventative commodities (condoms, bednets, water purification tabs, etc). In addition, many programs involve networks of not just doctors, but community health/outreach workers, for example a second tier of rural outreach workers to feed referrals into the clinics but also to provide counseling, testing and prevention services and reach very rural areas. This is a potential point for collaboration/ value add to IPCs, because these networks of trained health workers already exist and could be utilized and adapted to help on the implementation side IPCs.The challenge is financingChallengesEasier to provide fee for service through private providers – motivation is profit, people don’t pay for prevention. What’s hard is finding a way to subsidize preventative services. Need a third party payer. Ways to do it through government partnerships, demand-side financing, vouchersLarge experiments going on to make it happen, but it’s a challengeDSF / voucher systems could work for IPCs if the campaign is government or privately-funded, and there is potential for innovative funding mechanisms because the providers are receiving additional perks such as branding and increased clientele, etc.
The critical role of NGOs, FBOs, and for profits in IPCs that we see is to provide large scale networks of providers, retailers, clinics, or hospitals, that can be leveraged for large-scale standardized replication of services and operations such as IPCIf everyone goes to private sector for care, those actors must be part of prevention campaigns as well – in fact they are already participating in many ways that can beThe challenge is working with lots of private outlets (you need to) I gave one example, this is an achievable, realistic goal, and if we want to reach the majority, this has to be one of the delivery systems for IPCThe challenge here is that the funding models are less applicable – private providers still make a profit on consultations and commodities, which